Recombinant multi-species MTMR14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MTMR14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a myotubularin-related protein. The encoded protein is a phosphoinositide phosphatase that specifically dephosphorylates phosphatidylinositol 3,5-biphosphate and phosphatidylinositol 3-phosphate. Mutations in this gene are correlated with autosomal dominant centronuclear myopathy. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 18.[provided by RefSeq, Apr 2010]
The Alternative Names of target: 1110061O04Rik,5-bisphosphate 3-phosphatase MTMR14,C3orf29,HCV NS5A-transactivated protein 4 splice variant A-binding protein 1 (NS5ATP4ABP1),MTMR14,Mtmr14,Myotubularin-related protein 14,Phosphatidylinositol-3,Phosphatidylinositol-3-phosphate phosphatase,RGD1304842,hJumpy,jumpy

Target products collectionGo to MTMR14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1563-Ag-1/ GM-Tg-hg-SE1563-Ag-2 Human MTMR14 protein Human
GM-Tg-rg-SE1563-Ag-1/ GM-Tg-rg-SE1563-Ag-2 Rat MTMR14 protein Rat
GM-Tg-mg-SE1563-Ag-1/ GM-Tg-mg-SE1563-Ag-2 Mouse MTMR14 protein Mouse
GM-Tg-cynog-SE1563-Ag-1/ GM-Tg-cynog-SE1563-Ag-2 Cynomolgus/Rhesus macaque MTMR14 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1563-Ag-1/ GM-Tg-felg-SE1563-Ag-2 Feline MTMR14 protein Feline
GM-Tg-cang-SE1563-Ag-1/ GM-Tg-cang-SE1563-Ag-2 Canine MTMR14 protein Canine
GM-Tg-bovg-SE1563-Ag-1/ GM-Tg-bovg-SE1563-Ag-2 Bovine MTMR14 protein Bovine
GM-Tg-equg-SE1563-Ag-1/ GM-Tg-equg-SE1563-Ag-2 Equine MTMR14 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1563-Ag-1/ GM-Tg-hg-SE1563-Ag-2; GM-Tg-rg-SE1563-Ag-1/ GM-Tg-rg-SE1563-Ag-2;
GM-Tg-mg-SE1563-Ag-1/ GM-Tg-mg-SE1563-Ag-2; GM-Tg-cynog-SE1563-Ag-1/ GM-Tg-cynog-SE1563-Ag-2;
GM-Tg-felg-SE1563-Ag-1/ GM-Tg-felg-SE1563-Ag-2; GM-Tg-cang-SE1563-Ag-1/ GM-Tg-cang-SE1563-Ag-2;
GM-Tg-bovg-SE1563-Ag-1/ GM-Tg-bovg-SE1563-Ag-2; GM-Tg-equg-SE1563-Ag-1/ GM-Tg-equg-SE1563-Ag-2
Products Name MTMR14 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MTMR14
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MTMR14 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.